We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STERV:OMXHEXStora Enso Oyj Class R Analysis

Data as of 2026-03-11 - not real-time

€10.55

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Stora Enso’s share price sits at €10.55, comfortably above the computed support of €10.26 and below the resistance of €12.26, with the 20‑day SMA (€11.13) perched above both the 50‑day (€10.79) and 200‑day (€9.85) averages, signaling a bullish backdrop. RSI at 42.8 suggests the stock is not yet oversold nor overbought, while the MACD histogram is negative and the signal line is bearish, hinting at short‑term momentum weakness. Volume is on an increasing trend and the 30‑day volatility is high at 41%, reflecting active trading. Recent material news confirms a profit beat, a planned bond redemption of €500 million, and an upcoming AGM, all of which provide a positive catalyst backdrop.
Fundamentally, the stock trades at a forward PE of ~12 and a price‑to‑book of 0.77, with a dividend yield of 2.35% and a modest payout ratio of 28%, supporting dividend sustainability. The DCF‑derived fair value of €3.81 is far below the market price, yet analyst targets (median €12) and a 12.5% upside estimate suggest the market may be undervaluing the company relative to peers. Low beta (~0.19) indicates limited systematic risk, but high volatility and a “Greed” sentiment score (74.8) add caution. Overall, the blend of bullish technical positioning, solid dividend profile, and attractive valuation relative to analyst expectations makes the stock appealing for medium‑ to long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above key support with bullish SMA hierarchy
  • Bearish MACD signal indicating possible pull‑back
  • Increasing volume supporting price stability

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst median target of €12 exceeds current price
  • Solid dividend yield and low payout ratio
  • Profit beat and bond redemption improving balance‑sheet perception

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable renewable business model in packaging and biomaterials
  • Low beta and defensive dividend profile
  • Long‑term upside potential indicated by upside/downside estimate and sector fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth-2.90%
Profit Margin7.45%
P/E Ratio12.0
ROE6.65%
ROA0.75%
Debt/Equity42.01
P/B Ratio0.8
Op. Cash Flow€645.0M
Free Cash Flow€-297875008

Technical Analysis

TrendBullish
RSI42.8
Support€10.26
Resistance€12.26
MA 20€11.13
MA 50€10.79
MA 200€9.85
MACDBearish
VolumeIncreasing
Fear & Greed Index74.79

Valuation

Fair Value€3.81
Target Price€11.88
Upside/Downside12.56%
GradeUndervalued
TypeValue
Dividend Yield2.35%

Risk Assessment

Beta0.19
Volatility41.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.